» Articles » PMID: 24793141

Approaches to in Vitro Tissue Regeneration with Application for Human Disease Modeling and Drug Development

Overview
Specialty Pharmacology
Date 2014 May 6
PMID 24793141
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Reliable in vitro human disease models that capture the complexity of in vivo tissue behaviors are crucial to gain mechanistic insights into human disease and enable the development of treatments that are effective across broad patient populations. The integration of stem cell technologies, tissue engineering, emerging biomaterials strategies and microfabrication processes, as well as computational and systems biology approaches, is enabling new tools to generate reliable in vitro systems to study the molecular basis of human disease and facilitate drug development. In this review, we discuss these recently developed tools and emphasize opportunities and challenges involved in combining these technologies toward regenerative science.

Citing Articles

Use and application of organ-on-a-chip platforms in cancer research.

Yu Y, Zhou T, Cao L J Cell Commun Signal. 2023; 17(4):1163-1179.

PMID: 38032444 PMC: 10713514. DOI: 10.1007/s12079-023-00790-7.


Multiparametric Material Functionality of Microtissue-Based In Vitro Models as Alternatives to Animal Testing.

Stengelin E, Thiele J, Seiffert S Adv Sci (Weinh). 2022; 9(10):e2105319.

PMID: 35043598 PMC: 8981905. DOI: 10.1002/advs.202105319.


Transcending toward Advanced 3D-Cell Culture Modalities: A Review about an Emerging Paradigm in Translational Oncology.

Farhat J, Pandey I, Alwahsh M Cells. 2021; 10(7).

PMID: 34359827 PMC: 8304089. DOI: 10.3390/cells10071657.


A Roadmap of In Vitro Models in Osteoarthritis: A Focus on Their Biological Relevance in Regenerative Medicine.

Bartolotti I, Roseti L, Petretta M, Grigolo B, Desando G J Clin Med. 2021; 10(9).

PMID: 33925222 PMC: 8124812. DOI: 10.3390/jcm10091920.


Microengineered 3D pulmonary interstitial mimetics highlight a critical role for matrix degradation in myofibroblast differentiation.

Matera D, DiLillo K, Smith M, Davidson C, Parikh R, Said M Sci Adv. 2020; 6(37).

PMID: 32917680 PMC: 11206459. DOI: 10.1126/sciadv.abb5069.


References
1.
Hanna J, Wernig M, Markoulaki S, Sun C, Meissner A, Cassady J . Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007; 318(5858):1920-3. DOI: 10.1126/science.1152092. View

2.
Park J, Koito H, Li J, Han A . Microfluidic compartmentalized co-culture platform for CNS axon myelination research. Biomed Microdevices. 2009; 11(6):1145-53. PMC: 2783938. DOI: 10.1007/s10544-009-9331-7. View

3.
Bae H, Puranik A, Gauvin R, Edalat F, Carrillo-Conde B, Peppas N . Building vascular networks. Sci Transl Med. 2012; 4(160):160ps23. PMC: 3569029. DOI: 10.1126/scitranslmed.3003688. View

4.
Lii J, Hsu W, Parsa H, Das A, Rouse R, Sia S . Real-time microfluidic system for studying mammalian cells in 3D microenvironments. Anal Chem. 2008; 80(10):3640-7. DOI: 10.1021/ac8000034. View

5.
Chambers S, Fasano C, Papapetrou E, Tomishima M, Sadelain M, Studer L . Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009; 27(3):275-80. PMC: 2756723. DOI: 10.1038/nbt.1529. View